Skip to content

NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers

NRC: Improving Healthcare for Cognitively Impaired Elders and Their Caregivers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03289377
Acronym
RDAD&APNs
Enrollment
50
Registered
2017-09-21
Start date
2018-02-01
Completion date
2018-10-31
Last updated
2018-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Nurse Training

Brief summary

An multi-stage mixed-method design will be employed to obtain both qualitative and quantitative data to address two study aims: (1) Evaluate and refine the delivery Reducing Disabilities in Alzheimer's Disease (RD- AD) training to advanced practice nurses and (2) Evaluate and refine the implementation of RD-AD by advanced practice nurses in their medical settings.

Detailed description

Two waves of APNs (25 each wave/total 50) will receive RDAD training and be queried pre and post- training using both qualitative and quantitative procedures to determine: (1) Is RDAD training successfully received by advanced practice nurses? (2) Do they report it as relevant to improving the care they deliver to persons with Alzheimer's Disease and Related Dementias (ADRD)? (3) Does RDAD training of advanced practice nurses improve their level of knowledge about ADRD, their skills in providing ADRD care, and their level of confidence in providing this care? A subset of advanced practice nurses (5 per wave, total of 10) will be recruited to implement RDAD as part of their ongoing care of persons with ADRD.

Interventions

BEHAVIORALRDAD Training

An interactive processes of lecture, role-play, and discussion, APNs will have the opportunity to dissect all phases of RDAD to insure they understand the objectives, can enact the program, and feel confident they can problem-solve situations that arise. APNs will receive materials to insure they are knowledgeable about ADRD symptoms, behavior management techniques, and exercise safety.

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Licensed by the Washington state Department of Health as an Advanced Registered Nurse Practitioner (ARNP), * Hold a board certification as a Gerontological Nurse Practitioner, Adult Nurse Practitioner, or Family Nurse Practitioner, * Work at least half time (0.50 FTE) in a clinical setting (primary care, internal medicine, sub-specialty, medical home), with a panel consisting of over 25% of patients over 65 years of age, * Have no expectation for termination over the course of the study; and * Agree to participate in all phases of the RDAD translational program.

Exclusion criteria

* NA

Design outcomes

Primary

MeasureTime frameDescription
Physician Confidence in Dementia Care SkillsChange from baseline score at 2 monthsA 12-item self-report measure (administered to ARNPs) designed to measure perception of ability to address the care needs of patients with ADRD.
Sense of Competence in DementiaChange from baseline score at 2 monthsA 17-item questionnaire covering 4 domains: job satisfaction, attitude towards dementia, work experience, and level of dementia knowledge.
Dementia Attitudes ScaleChange from baseline score at 2 monthsA 20-item scale to measures attitudes towards dementia with a two-factor structure; dementia knowledge and social comfort.

Secondary

MeasureTime frameDescription
Focus Group QuestionsAt 2 monthsQuestions to determine satisfaction with a acceptability of RDAD
Implementation QuestionsAt 2 monthsQuestions to determine Acceptability of RDAD

Countries

United States

Contacts

Primary ContactChristine A Coulter, Ph.D.
cac76@uw.edu206-685-9169
Backup ContactAmy L Cunningham, M.S.
amoore@uw.edu206-616-5550

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026